10.94
+0.01(+0.09%)
Currency In USD
| Previous Close | 10.93 |
| Open | 10.93 |
| Day High | 10.94 |
| Day Low | 10.91 |
| 52-Week High | 10.94 |
| 52-Week Low | 1.94 |
| Volume | 9,413 |
| Average Volume | 95,985 |
| Market Cap | 18.84M |
| PE | -7.93 |
| EPS | -1.38 |
| Moving Average 50 Days | 7.29 |
| Moving Average 200 Days | 4.73 |
| Change | 0.01 |
If you invested $1000 in Evoke Pharma, Inc. (EVOK) 10 years ago, it would be worth $21.57 as of December 04, 2025 at a share price of $10.94. Whereas If you bought $1000 worth of Evoke Pharma, Inc. (EVOK) shares 5 years ago, it would be worth $24.74 as of December 04, 2025 at a share price of $10.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
GlobeNewswire Inc.
Nov 04, 2025 12:00 PM GMT
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in Cash Represents a 139.7% premium to most recent Nasdaq closing price Transaction expected to close by the end of 2025 SOLANA BEACH, Calif., and VERO BEACH, Fla., Nov. 04,
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
GlobeNewswire Inc.
Aug 26, 2025 11:00 AM GMT
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement Gimoti Specialty Pharmacy Network to Almost Double with Additional Relationships SOLANA BEACH, Calif. and CHICAGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
GlobeNewswire Inc.
Aug 21, 2025 11:00 AM GMT
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spra